Ruti Aga and the Old Prescription Pad: Why Six Years, Not Two

One detail in the Athletics Integrity Unit (AIU) statement took me four readings. The prescription Ruti Aga submitted to explain her positive test was written on an old pad, torn from the former workplace of the person who signed it. The clinic printed on that pad does not exist. The signatory is a family member with no medical registration. The facility where that person claimed to have worked told the AIU plainly that she had never been employed there.

Six years. Ruti Aga, 32, winner of the 2026 Tokyo Marathon and a three-time runner-up at World Marathon Majors races, is suspended from 10 September.

Every injury is a verdict, and I am only the one who reads it with my own legs. This time the verdict sat in no one's knee. It sat on a piece of paper.

The sequence needs restoring. In March, Aga won a half marathon in China. The sample taken there came back positive for methylprednisolone. Aga explained that she was treating a knee injury. The AIU did not argue about the knee. The AIU argued about the paper.

Methylprednisolone is a synthetic glucocorticoid, a corticosteroid, not an anabolic steroid. It sits in WADA class S9, prohibited in-competition only, and is a Specified Substance — a category the rules acknowledge may be linked to inadvertent use or genuine treatment. That classification set the baseline sanction: two years.

The rest of the file is four years for tampering during results management. Two sanctions served consecutively, not concurrently. Total: six years.

In the injury-code dataset I built in 2026, covering 547 athletes across 15 seasons, one column always gets filled before the injury column itself: who writes the medical paperwork. That column is almost always empty. The Ruti Aga case began in that emptiness.

Read as arithmetic, the verdict is simple. The tampering was punished twice as heavily as the doping itself: four years against two. The most expensive item in this file was not the vial. It was the form.

The architecture of the WADA Code explains the rest. Falsifying documentation during results management is an independent violation with a four-year baseline. Where an athlete commits multiple violations, the sanctions run back-to-back rather than side-by-side. Concealment does not soften a penalty; it stacks a second verdict on top of the first.

Hip rotation never lies, only the people who insist on misreading it. A prescription lies quickly, and gets caught faster.

The road that was available: had Aga held a valid Therapeutic Use Exemption for a genuine knee condition, a positive for a Specified Substance might have been no violation at all, or a far lighter one. Had she simply disclosed treating herself without a TUE, the file still had a mitigation door. The forged paper shut it. The blind spot was never the needle. It was that nobody around Aga understood the paper would be checked too.

And it was checked quickly. The AIU called the clinic named on the form; the clinic confirmed the prescription was not theirs. The professional register showed the signatory held no licence. The former employer confirmed she had never been on staff. Four layers of verification, one direction.

The economics of the road matter here as well. Chinese half marathons are a dense appearance-fee market for East African runners — high volume, lighter scrutiny than the majors. The March result is almost certainly annulled, prize money included. That is a loss outside sport.

At national level the effect rounds to zero. Ethiopia's women's marathon bench is deep enough to absorb one absence without the results board moving. Aga was one knot in a very dense net. What suffers is the commercial credibility of the East African road-running brand, which carries real value for organisers and sponsors.

On age, the numbers speak without help. Aga is 32. The women's marathon peak commonly runs to around 35, occasionally beyond. A six-year ban puts her back at a start line near 38, after six years without elite racing. The data promises nothing there.

The easiest thing to misread is the label. Many reports called methylprednisolone a steroid. It is a corticosteroid, an entirely different class, and that is precisely the softer half of this case. The wrong word makes the public picture a textbook doping bust, when the pharmacology may amount to careless injury treatment. The doping half of this file is the most forgivable half.

Another reflex needs blocking: the inference that this reveals organised doping in Ethiopia. The evidence points the other way. A clinic that does not exist, a used prescription pad, a relative with no licence — that is the sophistication level of someone with no adviser, not of a staged system. The clumsiness is itself the diagnosis: around this athlete there was no decent medical or legal scaffolding.

Which leads to a deterrence paradox. The longer the ban, the more it lands on whoever had the least compliance infrastructure to begin with. Athletes with counsel obtain a TUE before the injection. Athletes without counsel go looking for an old pad.

I do not prophesy; I only read the code the body wrote in advance. The code in this case was written on paper, not in tendon or ligament.

Whether the AIU widens its inquiry to whoever advised or assembled the defence remains open. A retrospective review of stored samples and the biological passport is plausible. And Chinese race organisers may tighten medical-document vetting for invited athletes.

Injury is the one thing on the road that never negotiates. Paperwork does negotiate — and the price is always paid in seasons. The question left for every training group is simple: in the file of the athlete you guide, whose name goes on the last medical form?